Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 053184/0705 | |
| Pages: | 5 |
| | Recorded: | 07/10/2020 | | |
Attorney Dkt #: | TP4000-NAME CHANGE UPLOAD |
Conveyance: | CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
8
|
|
Patent #:
|
|
Issue Dt:
|
09/12/2017
|
Application #:
|
15158206
|
Filing Dt:
|
05/18/2016
|
Publication #:
|
|
Pub Dt:
|
11/24/2016
| | | | |
Title:
|
ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY
|
|
|
Patent #:
|
|
Issue Dt:
|
04/16/2019
|
Application #:
|
15673213
|
Filing Dt:
|
08/09/2017
|
Publication #:
|
|
Pub Dt:
|
11/23/2017
| | | | |
Title:
|
ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY
|
|
|
Patent #:
|
|
Issue Dt:
|
02/18/2020
|
Application #:
|
16279958
|
Filing Dt:
|
02/19/2019
|
Publication #:
|
|
Pub Dt:
|
06/13/2019
| | | | |
Title:
|
ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY
|
|
|
Patent #:
|
|
Issue Dt:
|
03/22/2022
|
Application #:
|
16462094
|
Filing Dt:
|
05/17/2019
|
Publication #:
|
|
Pub Dt:
|
02/13/2020
| | | | |
Title:
|
ALVOCIDIB PRODRUGS AND THEIR USE AS PROTEIN KINASE INHIBITORS
|
|
|
Patent #:
|
|
Issue Dt:
|
03/22/2022
|
Application #:
|
16462094
|
Filing Dt:
|
05/17/2019
|
Publication #:
|
|
Pub Dt:
|
02/13/2020
| | |
PCT #:
|
US2017062408
|
Title:
|
ALVOCIDIB PRODRUGS AND THEIR USE AS PROTEIN KINASE INHIBITORS
|
|
|
Patent #:
|
|
Issue Dt:
|
06/15/2021
|
Application #:
|
16703773
|
Filing Dt:
|
12/04/2019
|
Title:
|
CDK9 INHIBITORS AND POLYMORPHS THEREOF FOR USE AS AGENTS FOR TREATMENT OF CANCER
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16706463
|
Filing Dt:
|
12/06/2019
|
Publication #:
|
|
Pub Dt:
|
09/10/2020
| | | | |
Title:
|
METHODS FOR TREATING CASTRATION-RESISTANT AND CASTRATION-SENSITIVE PROSTATE CANCER
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16727693
|
Filing Dt:
|
12/26/2019
|
Publication #:
|
|
Pub Dt:
|
04/30/2020
| | | | |
Title:
|
ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY
|
|
Assignee
|
|
|
640 MEMORIAL DRIVE |
CAMBRIDGE, MASSACHUSETTS 02139 |
|
Correspondence name and address
|
|
DEBORAH A. MILLER
|
|
84 WATERFORD DRIVE
|
|
SUMITOMO DAINIPPON PHARMA AMERICA, INC.
|
|
MARLBOROUGH, MA 01752
|
Search Results as of:
06/24/2024 02:22 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|